R.H. Bluestein & Co’s Abercrombie & Fitch ANF Stock Holding History

R.H. Bluestein & Co’s Portfolio ANF Stock Details ANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,000	Closed	-$313K	–	387
2021 Q4	$313K	Hold	9,000	–	–	0.01%	310
2021 Q3	$339K	Buy	+9,000	New	+$348K	0.01%	291

Other funds holding ANF

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VLKIM

Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

CCM

Chimera Capital Management New York $210M AUM 21.21% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

R.H. Bluestein & Co's ANF Position: Q1 2022 in Review

R.H. Bluestein & Co sold out of Abercrombie & Fitch (ANF) in Q1 2022, closing a stake of 9,000 shares — an estimated $313K sold.

R.H. Bluestein & Co first reported a position in ANF in Q3 2021 and held it in 2 quarters. The position peaked at $339K in Q3 2021. 229 funds tracked by Wall St. Rank hold ANF as of Q1 2022.

R.H. Bluestein & Co reported no remaining Abercrombie & Fitch position as of Q1 2022 after selling out during the quarter.
R.H. Bluestein & Co sold 9,000 Abercrombie & Fitch shares in Q1 2022, an estimated $313K.
R.H. Bluestein & Co first reported a position in Abercrombie & Fitch in Q3 2021 and held it in 2 quarters.
R.H. Bluestein & Co's Abercrombie & Fitch position peaked at $339K in Q3 2021.
229 funds tracked by Wall St. Rank held Abercrombie & Fitch as of Q1 2022.

Based on R.H. Bluestein & Co's 13F filing for Q1 2022, filed 11 May 2022.